Back to Post Cycle Therapy - PCT

Arimidex Anastrozole - PHARMAQO

Price: £45
No tax

Buy Arimidex (Anastrozole) UK from Power Anabolics — genuine Pharmaqo Labs anastrozole 1mg tablets, dispatched the same working day from our UK warehouse with discreet next-day tracked delivery.

Anastrozole is a non-steroidal aromatase inhibitor used on cycle to control oestrogen conversion when running aromatising compounds such as testosterone, Dianabol or Deca. Every batch is independently lab-tested for purity and dose accuracy, and each box can be verified via the Pharmaqo authenticity check on the brand's website.

  • Brand: Pharmaqo Labs (UK favourite)
  • Active: Anastrozole 1mg per tablet
  • Use: On-cycle E2 control — not for PCT
  • Dispatch: Same-day from UK, next-day tracked delivery
  • Payment: Bitcoin, Lightning, bank transfer
Anastrozole1 mg/tab

Active half-life Active half-life 40–50 hours
Dosage Dosage

0.25–0.5 mg EOD on cycle

Acne Acne No
Water retention Water retention No
HBR HBR (high blood-pressure risk) No
Hepatotoxicity Hepatotoxicity No
Detection time Detection time

Arimidex is the most widely used aromatase inhibitor for cycle support in the UK because of its predictable, dose-dependent oestrogen suppression. Sensible practice is to start low — 0.25 mg every other day — and adjust based on bloodwork rather than guesswork. Order before 3pm for same working-day dispatch with discreet packaging across the UK.

Product availability: Last items in stock
Share

Arimidex Anastrozole Pharmaqo for sale in the UK

Arimidex by Pharmaqo Labs is an oral 1mg anastrozole tablet used on cycle by anabolic steroid users to control oestrogen levels and reduce the risk of gynecomastia, water retention and high blood pressure caused by aromatising compounds. If you want to buy Anastrozole UK from a verified source, every batch sold here is lab-tested and shipped same working day from our UK warehouse.

What is Anastrozole?

Anastrozole is a non-steroidal, third-generation aromatase inhibitor first developed by Zeneca (now AstraZeneca) and approved in 1995 under the brand name Arimidex for the treatment of hormone-receptor-positive breast cancer in postmenopausal women. It works by reversibly binding to the aromatase enzyme, the enzyme that converts androgens into oestrogens in peripheral tissues. At a clinical 1 mg/day dose, anastrozole suppresses circulating oestradiol (E2) by roughly 85 percent. Its active half-life is 40–50 hours, which makes every-other-day or every-third-day dosing practical and means blood E2 levels respond gradually rather than crashing within hours. Because it is a true enzyme inhibitor and not a SERM, anastrozole reduces total oestrogen rather than blocking it at the receptor.

Arimidex Anastrozole benefits

  • Suppresses circulating oestradiol by approximately 85% at clinical doses
  • Reduces gynecomastia risk on aromatising cycles such as testosterone, Dianabol or Deca
  • Cuts oestrogen-driven water retention and bloating, giving a harder, drier look
  • Lowers oestrogen-mediated blood pressure spikes during heavy bulks
  • Long 40–50 hour half-life allows convenient EOD or E3D dosing

Arimidex is the standard ancillary for users who already know their cycle aromatises and want predictable, dose-dependent E2 control rather than receptor blockade.

Arimidex dosage and cycle

Typical on-cycle dose: 0.25–0.5 mg every other day (EOD), sometimes every third day (E3D), running for the duration of the aromatising cycle. Beginners: start at 0.25 mg EOD and reassess. Higher-dose or more aromatising cycles: 0.5 mg EOD is often sufficient — doses above 1 mg/day are almost never needed for performance use. Anastrozole is used on cycle alongside testosterone or other aromatising compounds — it is not a PCT drug and should not be relied on to restart natural testosterone production after a cycle. Crashed oestrogen is genuinely harmful — symptoms include joint pain, low libido, fatigue and poor lipid profiles — so the correct approach is to start low and dial in based on bloodwork, not chase a "zero E2" target.

Side effects and use notes

Anastrozole itself does not aromatise, is not hepatotoxic and does not cause acne, water retention or significant blood-pressure issues. The main risks come from over-suppression of oestrogen: joint dryness and aching, reduced libido, erectile dysfunction, lethargy, low mood and worsening of HDL cholesterol. Long-term oestrogen suppression also impacts bone-mineral density, which is why on-cycle use should be dose-adjusted to the cycle and not run indefinitely. For prolactin-driven side effects on 19-nor cycles (Tren, Deca, NPP), anastrozole is the wrong tool — use a dopamine agonist such as Cabaser (Cabergoline) instead. After the cycle ends, switch to a SERM-based PCT — anastrozole does not restart the HPTA.

Stacks well with

Anastrozole pairs with virtually any aromatising AAS cycle. Most users run it alongside a testosterone base such as Test E 300, then transition to Nolvadex (Tamoxifen) for post-cycle therapy once the long-ester compounds clear. For tren or deca-based cycles, add Cabaser for prolactin control rather than relying on Arimidex alone.

Frequently asked questions

How long does Arimidex take to start working?

Anastrozole begins inhibiting aromatase within hours of the first dose, but circulating oestradiol falls progressively over several days as the enzyme is blocked across peripheral tissues. With a 40–50 hour half-life and EOD dosing, steady-state E2 suppression is usually established within a week and bloodwork is best repeated 2–4 weeks into the cycle to confirm the dose is dialled in.

Is Arimidex suitable for first-time users?

Arimidex is appropriate for first-time users who are running an aromatising cycle and want predictable oestrogen control, but it is not a beginner cycle ingredient by itself. Start at the lowest practical dose (0.25 mg EOD), and avoid taking it "just in case" — running an AI without an aromatising compound, or chasing zero E2, causes more problems than it solves.

Can Arimidex be detected on a drug test?

Anastrozole is on the WADA prohibited list as an anti-oestrogenic agent and is detectable by GC-MS/LC-MS in athletes subject to drug testing. Detection windows vary by lab sensitivity and dose. Performance/recreational use is not the same context as competitive sport — anyone subject to sanctioned testing should be aware that AIs are screened for, not just AAS.

  • Brand
  • In stock
    3 Items
Discreet & Secure
Plain unmarked packaging — no shop name on label. We never store card data.
Fast UK Delivery
Same-day dispatch before 3pm. Free tracked Royal Mail over £100.
Lost in Transit? We Replace It
Sealed pharmaceuticals can not be returned for safety reasons. If your parcel is lost in transit, we send a free replacement — just contact us.

Comments (0)

No customer reviews for the moment.

4 other products in the same category

Viewed products

Clients also bought

HCG EUTRIG-HP 5000 IU
£25
Rated out of 5 stars based on review(s)
MENT 50 - PHARMAQO
£77
Rated out of 5 stars based on review(s)
Loading...
Back to top